Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins

Journal of Cell Biology

Volumn 142, Issue 3, 1998, Pages 625-633

  Lenormand, Philippe ^a,b   Brondello, Jean Marc ^a   Brunet, Anne ^a   Pouysségur, Jacques ^a  

^a CENTRE DE BIOCHIMIE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Cell compartmentation; Cell nucleus; Growth factors; Protein kinases; Signal transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR PROTEIN;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHIMERA; CHINESE HAMSTER; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENZYME ACTIVATION; ENZYME INHIBITION; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL TRANSPORT; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL LINE; CELL NUCLEUS; CRICETINAE; CRICETULUS; CYSTEINE ENDOPEPTIDASES; ENZYME ACTIVATION; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GROWTH SUBSTANCES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SYNTHESIS INHIBITORS; PROTEINS; PROTO-ONCOGENE PROTEINS C-RAF; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0031852068     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.142.3.625     Document Type: Article

References (48)

1. Ahn, N.G., R. Seger, and E.G. Krebs. 1992. The mitogen-activated protein kinase activator. Curr. Opin. Cell Biol. 4:992-999.
2. Alessi, D.R., A. Cuenda, P. Cohen, D.T. Dudley, and A.R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489-27494.
3. Bardwell, L., J.G. Cook, E.C. Chang, B.R. Cairns, and J. Thorner. 1996. Signaling in the yeast pheromone response pathway: specific and high-affinity interaction of the mitogen-activated protein (MAP) kinases Kss1 and Fus3 with the upstream MAP kinase kinase Ste7. Mol. Cell. Biol. 16: 3637-3650.
4. Baumeister, W., and A. Lupas. 1997. The proteasome. Curr. Opin. Struct. Biol. 7:273-278.
5. Bjorkoy, G., M. Perander, A. Overvatn, and T. Johansen. 1997. Reversion of Ras-and phosphatidylcholine-hydrolyzing phospholipase C-mediated transformation of NIH 3T3 cells by a dominant interfering mutant of protein kinase C lambda is accompanied by the loss of constitutive nuclear mitogen-activated protein kinase/extracellular signal-regulated kinase activity. J. Biol. Chem. 272:11557-11565.
6. Boulton, T.G., S.H. Nye, D.J. Robbins, N.Y. Ip, E. Radziejewska, S.D. Morgenbesser, R.A. DePinho, N. Panayotatos, M.H. Cobb, and G.D. Yancopoulos. 1991. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell. 65:663-675.
7. Brondello, J.M., A. Brunet, J. Pouyssegur, and F.R. McKenzie. 1997. The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J. Biol. Chem. 272:1368-1376.
8. Chen, T.H., C. Sarnecki, and J. Blenis. 1992. Nuclear localization and regulation of ERK-and RSK-encoded protein kinases. Mol. Cell. Biol. 12: 915-927.
9. Cowley, S., H. Paterson, P. Kemp, and C.J. Marshall. 1994. Activation of MAP kinase kinase is both necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 77:841-852.
10. Crews, C.M., A. Alessandrini, and R.L. Erikson. 1992. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science. 258:478-480.
11. Dick, L.R., C.R. Moomaw, B.C. Pramanik, G.N. DeMartino, and C.A. Slaughter. 1992. Identification and localization of a cysteinyl residue critical for the trypsin-like catalytic activity of the proteasome. Biochemistry. 31:7347-7355.
12. Dudley, D.T., L. Pang, S.J. Decker, A.J. Bridges, and A.R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA. 92:7686-7689.
13. Fenteany, G., R.F. Standaert, W.S. Lane, S. Choi, E.J. Corey, and S.L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science. 268:726-731.
14. Fukuda, M., I. Gotoh, Y. Gotoh, and E. Nishida. 1996. Cytoplasmic localization of MAP kinase kinase directed by its N-terminal, leucin-rich amino acid sequence, which acts as a nuclear export signal. J. Biol. Chem. 271:20024-20028.
15. Fukuda, M., Y. Gotoh, and E. Nishida. 1997. Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase. EMBO (Eur. Mol. Biol. Organ.) J. 16: 1901-1908.
16. TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature. 358:414-424.
17. Gille, H., M. Kortenjann, O. Thomae, C. Moomaw, C. Slaughter, M.H. Cobb, and P.E. Shaw. 1995. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO (Eur. Mol. Biol. Organ.) J. 14:951-962.
18. Gonzalez, F.A., A. Seth, D.L. Raden, D.S. Bowman, F.S. Fay, and R.J. Davis. 1993. Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J. Cell Biol. 122:1089-1101.
19. Groom, L.A., A.A. Sneddon, D.R. Alessi, S. Dowd, and S.M. Keyse. 1996. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO (Eur. Mol. Biol. Organ.) J. 15:3621-3632.
20. Guan, K.L., and E. Butch. 1995. Isolation and characterization of a novel dual specific phosphatase, HVH2, which selectively dephosphorylates the mitogen-activated protein kinase. J. Biol. Chem. 270:7197-7203.
21. Hipskind, R.A., M. Baccarini, and A. Nordheim. 1994. Transient activation of Raf-1, MEK and ERK2 coincides kinetically with ternary complex factor phosphorylation and immediate-early gene promoter activity in vivo. Mol. Cell. Biol. 14:6219-6231.
22. Hoffman, L., and M. Rechsteiner. 1996. Nucleotidase activities of the 26 S proteasome and its regulatory complex. J. Biol. Chem. 271:32538-32545.
23. Jaaro, H., H. Rubinfeld, T. Hanoch, and R. Seger. 1997. Nuclear translocation of mitogen-activated protein kinase kinase (MEK1) in response to mitogenic stimulation. Proc. Natl. Acad. Sci. USA. 94:3742-3747.
24. Jaffa, A.A., B.S. Miller, S.A. Rosenzweig, P.S. Naidu, V. Velarde, and R.K. Mayfield. 1997. Bradykinin induces tubulin phosphorylation and nuclear translocalion of MAP kinase in mesangial cells. Am. J. Physiol. 273: F916-F924.
25. Johnson, G.L., and R.R. Vaillencourt. 1994. Sequential protein kinase reactions controlling cell growth and differentiation. Curr. Opin. Cell Biol. 6:230-238.
26. Khokhlatchev, A.V., B. Canagarajah, J. Wilsbacher, M. Robinson, M. Atkinson, E. Goldsmith, and M.H. Cobb. 1998. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell. 93:605-615.
27. Lenormand, P., C. Sardet, G. Pagès, G. L'Allemain, A. Brunet, and J. Pouysségur. 1993. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J. Cell Biol. 122:1079-1089.
28. Lenormand, P., M. McMahon, and J. Pouysségur. 1996. Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway. J. Biol. Chem. 271:15762-15768.
29. Marais, R., J. Wynne, and R. Treisman. 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell. 73:381-393.
30. Martin, K.C., D. Michael, J.C. Rose, M. Barad, A. Casadio, H. Zhu, and E.R. Kandel. 1997. MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-term facilitation in Aplysia. Neuron. 18:899-912.
31. Meili, R., and H.K. Ballmer. 1996. Activation-independent nuclear translocation of mitogen activated protein kinase ERK1 mediated by thiol-modifying chemicals. FEBS Lett. 394:34-38.
32. Mii, S., R.A. Khalil, K.G. Morgan, J.A. Ware, and K.C. Kent. 1996. Mitogen-activated protein kinase and proliferation of human vascular smooth muscle cells. Am. J. Physiol. 270:H142-H150.
33. Minden, A., M. McMahon, C. Lange-Carter, B. Dérijar, R.J. Davis, and G.L. Johnson. 1994. Differential activation of ERK and JNK by Raf-1 and MEKK. Science. 266:1719-1723.
34. Misra-Press, A., C.S. Rim, H. Yao, M.S. Roberson, and P.J. Stork. 1995. A novel mitogen-activated protein kinase phosphatase. Structure, expression, and regulation. J. Biol. Chem. 270:14587-14596.
35. Moriguchi, T., Y. Gotoh, and E. Nishida. 1995. Activation of two isoforms of mitogen-activated protein kinase kinase in response to epidermal growth factor and nerve growth factor. Eur. J. Biochem. 234:32-38.
36. Muda, M., U. Boschert, R. Dickinson, J.C. Martinou, I. Martinou, M. Camps, W. Schlegel, and S. Arkinstall. 1996. MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J. Biol. Chem. 271:4319-4326.
37. Nguyen, T.T., J.C. Scimeca, C. Filloux, P. Peraldi, J.L. Carpentier, and O.E. Van. 1993. Co-regulation of the mitogen-activated protein kinase, extracellular signal-regulated kinase 1, and the 90-kDa ribosomal S6 kinase in PC12 cells. Distinct effects of the neurotrophic factor, nerve growth factor, and the mitogenic factor, epidermal growth factor. J. Biol. Chem. 268:9803-9810.
38. Nigg, E.A. 1997. Nucleocytoplasmic transport: signals, mechanisms and regulation. Nature. 386:779-787.
39. Pahl, H.L., and P.A. Baeuerle. 1996. Control of gene expression by proteolysis. Curr. Opin. Cell Biol. 8:340-347.
40. Pante, N., and U. Aebi. 1996. Sequential binding of import ligands to distinct nucleopore regions during their nuclear import. Science. 273:1729-1732.
41. Robinson, M.J., and M.H. Cobb. 1997. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9:180-186.
42. Rock, K.L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A.L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78:761-771.
43. Samuels, M.L., and M. McMahon. 1994. Inhibition of platelet-derived growth factor-and epidermal growth factor-mediated mitogenesis and signaling in 3T3 cells expressing delta Raf-1:ER, an estradiol-regulated form of Raf-1. Mol. Cell. Biol. 14:7855-7866.
44. Samuels, M.L., M.J. Weber, M. Bishop, and M. McMahon. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol. Cell. Biol. 13:6241-6252.
45. Sun, H., C.H. Charles, L.F. Lau, and N.K. Tonks. 1993. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell. 75:487-493.
46. Vinitsky, A., C. Michaud, J.C. Powers, and M. Orlowski. 1992. Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex. Biochemistry. 31:9421-9428.
47. Zheng, C.-F., and K.-L. Guan. 1993. Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2. J. Biol. Chem. 268:11435-11439.
48. Zheng, C.-F., and K.-L. Guan. 1994. Cytoplasmic localization of the mitogen-activated protein kinase activator MEK. J. Biol. Chem. 269:19947-19952.